HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shun-Fa Yang Selected Research

Coronary Artery Disease (Coronary Atherosclerosis)

1/2020Variations of the proprotein convertase subtilisin/kexin type 9 gene in coronary artery disease.
1/2016Relationship of Genetic Polymorphisms of Aldosterone Synthase Gene Cytochrome P450 11B2 and Mineralocorticoid Receptors with Coronary Artery Disease in Taiwan.
1/2015Impact of Intercellular Adhesion Molecule-1 Genetic Polymorphisms on Coronary Artery Disease Susceptibility in Taiwanese Subjects.
1/2015Relationship of Genetic Polymorphisms of the Chemokine, CCL5, and Its Receptor, CCR5, with Coronary Artery Disease in Taiwan.
3/2013The impact of IGF-I gene polymorphisms on coronary artery disease susceptibility.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shun-Fa Yang Research Topics

Disease

270Neoplasms (Cancer)
05/2024 - 01/2003
101Neoplasm Metastasis (Metastasis)
04/2024 - 07/2004
85Mouth Neoplasms (Oral Cancer)
01/2024 - 06/2003
56Hepatocellular Carcinoma (Hepatoma)
05/2024 - 09/2003
47Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2024 - 07/2007
46Carcinogenesis
03/2024 - 10/2007
37Squamous Cell Carcinoma of Head and Neck
01/2023 - 06/2003
34Inflammation (Inflammations)
03/2022 - 06/2002
28Osteosarcoma (Osteogenic Sarcoma)
12/2023 - 06/2004
23Lymphatic Metastasis
03/2024 - 03/2008
23Pneumonia (Pneumonitis)
01/2021 - 02/2005
22Carcinoma (Carcinomatosis)
01/2023 - 04/2005
21Adenocarcinoma of Lung
03/2024 - 05/2012
20Lung Neoplasms (Lung Cancer)
03/2024 - 07/2004
20Prostatic Neoplasms (Prostate Cancer)
10/2023 - 09/2013
15Pelvic Inflammatory Disease (Pelvic Inflammatory Diseases)
01/2015 - 01/2008
14Infections
01/2022 - 06/2006
13Nasopharyngeal Carcinoma
03/2023 - 03/2010
11Disease Progression
07/2022 - 03/2003
10Renal Cell Carcinoma (Grawitz Tumor)
01/2024 - 10/2011
10Diabetes Mellitus
01/2023 - 04/2008
10Hypoxia (Hypoxemia)
08/2022 - 05/2012
10Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2020 - 10/2013
9Fibrosis (Cirrhosis)
12/2022 - 03/2009
9Hypertension (High Blood Pressure)
06/2022 - 03/2013
9Osteoarthritis
01/2022 - 01/2004
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 04/2005
8Anorexia
07/2011 - 04/2005
7Type 2 Diabetes Mellitus (MODY)
01/2024 - 05/2021
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2022 - 10/2007
7Leukemia
12/2019 - 06/2005
6Mitochondrial Diseases (Mitochondrial Disease)
01/2023 - 01/2018
6Liver Neoplasms (Liver Cancer)
01/2023 - 06/2013
6Breast Neoplasms (Breast Cancer)
10/2021 - 09/2006
6Cardiovascular Diseases (Cardiovascular Disease)
08/2021 - 10/2009
6Atherosclerosis
01/2019 - 07/2002
6Oral Submucous Fibrosis
09/2014 - 02/2002
5Diabetic Retinopathy (Retinopathy, Diabetic)
05/2024 - 01/2022
5Head and Neck Neoplasms (Head and Neck Cancer)
01/2024 - 02/2013

Drug/Important Bio-Agent (IBA)

55Proteins (Proteins, Gene)FDA Link
05/2024 - 06/2002
41Matrix Metalloproteinases (MMPs)IBA
08/2023 - 06/2002
37Matrix Metalloproteinase 2 (Gelatinase A)IBA
10/2021 - 02/2002
36Messenger RNA (mRNA)IBA
03/2024 - 09/2003
32Biomarkers (Surrogate Marker)IBA
05/2024 - 01/2009
30Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
12/2023 - 07/2004
28MelatoninIBA
08/2023 - 03/2015
24Matrix Metalloproteinase 9 (Gelatinase B)IBA
03/2023 - 07/2002
22Plasminogen Activators (Plasminogen Activator)IBA
12/2023 - 07/2004
21Long Noncoding RNAIBA
05/2024 - 01/2019
19Environmental CarcinogensIBA
01/2020 - 03/2011
16FlavonoidsIBA
04/2024 - 01/2007
16CytokinesIBA
12/2023 - 06/2002
15Anti-Bacterial Agents (Antibiotics)IBA
01/2024 - 02/2005
14CaspasesIBA
05/2024 - 12/2013
14Peptide Hydrolases (Proteases)FDA Link
09/2020 - 03/2008
13p38 Mitogen-Activated Protein KinasesIBA
05/2024 - 10/2007
13CurcuminIBA
01/2024 - 03/2020
12Carbonic Anhydrase IXIBA
01/2022 - 01/2012
12GelatinIBA
10/2019 - 06/2003
12GelatinasesIBA
10/2009 - 06/2003
11ErbB Receptors (EGF Receptor)IBA
12/2022 - 01/2016
11AntioxidantsIBA
12/2021 - 10/2013
10Small Interfering RNA (siRNA)IBA
01/2023 - 11/2011
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 10/2004
10Lipocalin-2IBA
11/2022 - 05/2011
9Tissue Inhibitor of Metalloproteinase-3IBA
01/2023 - 09/2014
9A-factor (Streptomyces)IBA
05/2017 - 10/2009
8EnzymesIBA
04/2024 - 03/2003
8Tissue Inhibitor of Metalloproteinase-2IBA
11/2022 - 07/2002
8Cadherins (E-Cadherin)IBA
04/2022 - 09/2011
8Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2022 - 05/2007
8Mitogen-Activated Protein KinasesIBA
07/2019 - 04/2007
7Caspase 3 (Caspase-3)IBA
01/2024 - 02/2012
7JNK Mitogen-Activated Protein KinasesIBA
01/2024 - 04/2007
7Antineoplastic Agents (Antineoplastics)IBA
01/2023 - 05/2016
7MicroRNAs (MicroRNA)IBA
08/2022 - 01/2012
7HMGB1 Protein (HMG1)IBA
10/2020 - 04/2015
7pterostilbeneIBA
01/2019 - 01/2014
7Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
12/2016 - 09/2010
7Plasminogen Activator Inhibitor 1IBA
01/2015 - 06/2003
7FibrinolysinFDA Link
01/2011 - 05/2003
6tricetinIBA
04/2024 - 01/2015
6WW Domain-Containing OxidoreductaseIBA
01/2023 - 10/2016
6Type 4 Fibroblast Growth Factor ReceptorIBA
05/2021 - 01/2015
6PTX3 proteinIBA
01/2021 - 10/2011
6Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
05/2019 - 06/2010
6Urokinase Plasminogen Activator ReceptorsIBA
01/2019 - 02/2006
6Carbonic Anhydrases (Carbonic Anhydrase)IBA
09/2017 - 09/2003
6Glutathione Transferase (Glutathione S-Transferase)IBA
11/2011 - 04/2005
5Tumor Biomarkers (Tumor Markers)IBA
04/2024 - 01/2014
5Insulin-Like PeptidesIBA
01/2024 - 07/2010
5RNA (Ribonucleic Acid)IBA
01/2024 - 09/2019
5norcantharidinIBA
12/2022 - 01/2012
5Reactive Oxygen Species (Oxygen Radicals)IBA
08/2022 - 10/2007
5DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2014
5CarcinogensIBA
01/2022 - 12/2012

Therapy/Procedure

40Therapeutics
05/2024 - 06/2004
19Drug Therapy (Chemotherapy)
08/2023 - 01/2014
7Radiotherapy
08/2023 - 01/2015
5Prostatectomy (Retropubic Prostatectomy)
01/2023 - 04/2014